These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34496804)

  • 21. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
    PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis.
    Fitzpatrick C; Floyd K
    Pharmacoeconomics; 2012 Jan; 30(1):63-80. PubMed ID: 22070215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review.
    Baggaley RF; Vegvari C; Dimala CA; Lipman M; Miller RF; Brown J; Degtyareva S; White HA; Hollingsworth TD; Pareek M
    Wellcome Open Res; 2021; 6():51. PubMed ID: 37025515
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
    Mafirakureva N; Mukherjee S; de Souza M; Kelly-Cirino C; Songane MJP; Cohn J; Lemaire JF; Casenghi M; Dodd PJ
    PLoS Med; 2023 Sep; 20(9):e1004285. PubMed ID: 37672524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; Noori T; van der Werf MJ; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a tool to support country-level project planning.
    Nishikiori N; Van Weezenbeek C
    BMC Public Health; 2013 Feb; 13():97. PubMed ID: 23374118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
    Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
    Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of community active case-finding strategies for detection of tuberculosis in Cambodia: study protocol for a pragmatic cluster randomized controlled trial.
    Teo AKJ; Prem K; Evdokimov K; Ork C; Eng S; Tuot S; Chry M; Mao TE; Hsu LY; Yi S
    Trials; 2020 Feb; 21(1):220. PubMed ID: 32093778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis.
    Winetsky DE; Negoescu DM; DeMarchis EH; Almukhamedova O; Dooronbekova A; Pulatov D; Vezhnina N; Owens DK; Goldhaber-Fiebert JD
    PLoS Med; 2012; 9(11):e1001348. PubMed ID: 23209384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of active tuberculosis case finding strategies for immigrants in South Korea: Epidemiology and cost-effectiveness analysis.
    Park S; Sung C; Choi H; Lee YW; Kang Y; Kim HJ; Kim HY; Oh IH; Lee SH
    PLoS One; 2023; 18(4):e0283414. PubMed ID: 37079530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan.
    Hussain H; Mori AT; Khan AJ; Khowaja S; Creswell J; Tylleskar T; Robberstad B
    BMC Health Serv Res; 2019 Oct; 19(1):690. PubMed ID: 31606031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis active case finding in Cambodia: a pragmatic, cost-effectiveness comparison of three implementation models.
    James R; Khim K; Boudarene L; Yoong J; Phalla C; Saint S; Koeut P; Mao TE; Coker R; Khan MS
    BMC Infect Dis; 2017 Aug; 17(1):580. PubMed ID: 28830372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects.
    Gomes I; Dong C; Vandewalle P; Khan A; Creswell J; Dowdy D; Sohn H
    PLoS One; 2022; 17(9):e0270816. PubMed ID: 36156080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan.
    Kawatsu L; Uchimura K; Ohkado A
    Int J Tuberc Lung Dis; 2020 May; 24(5):506-511. PubMed ID: 32398200
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.